ELTX
#4197
Elicio Therapeutics, Inc. - Common Stock
3.2 9 USD
-0.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-5.46%
Monthly Change
-31.32%
6 month change
-58.93%
Year Change
-67.10%
Previous Close
3.4 8
Open
3.2 9
Low
3.2 9
High
3.2 9
Volume
18
Financials
- Market Capitalization 62.79 M
- Employee 33
- Founded 2011
- CEO N/A
- Website www.elicio.com
- Headquarter Delaware, United States
- FIGI BBG00444GM02
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.09
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4194 |  DOMH Dominari Holdings Inc. - Common Stock | 2.79 USD | -1.41% | -2.79% | -15.71% | -47.85% | 63.09 M USD | ||
| 4195 |  TCRX TScan Therapeutics, Inc. - Common Stock | 1.03 USD | -5.50% | -3.74% | +8.42% | -46.07% | 62.91 M USD | ||
| 4203 |  CING Cingulate Inc. - Common Stock | 4.68 USD | -4.68% | -11.70% | -6.59% | -24.03% | 62.13 M USD | ||
| 4214 |  EDSA Edesa Biotech, Inc. - Common Shares | 6.81 USD | -2.85% | -3.81% | +14.45% | +215.28% | 60.55 M USD |
Frequently asked questions about Elicio Therapeutics, Inc. - Common Stock
What is the Elicio Therapeutics, Inc. - Common Stock stock price today?
The current price of Elicio Therapeutics, Inc. - Common Stock (ELTX) is 3.29. Over the past 24 hours, the stock has changed by -5.46%. Follow the ELTX chart for real-time price dynamics.
What is the stock ticker of Elicio Therapeutics, Inc. - Common Stock?
Elicio Therapeutics, Inc. - Common Stock trades under the ticker ELTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Elicio Therapeutics, Inc. - Common Stock stock going up?
ELTX has changed by -0.30% over the last week, -31.32% over the last month, and -67.10% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Elicio Therapeutics, Inc. - Common Stock net income for the last quarter?
Elicio Therapeutics, Inc. - Common Stock reported net income of -11.82 M for the last quarter. The previous quarter showed -7.72 M, which means net income changed by -53.19%.
How many employees does Elicio Therapeutics, Inc. - Common Stock have?
As of the latest available data, Elicio Therapeutics, Inc. - Common Stock has 33 employees. Workforce size can provide additional context about the company's scale and operations.
What is Elicio Therapeutics, Inc. - Common Stock EBITDA?
Elicio Therapeutics, Inc. - Common Stock EBITDA is -10.47 M, and its EBITDA margin is -80.58 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Elicio Therapeutics, Inc. - Common Stock stock?
You can buy Elicio Therapeutics, Inc. - Common Stock (ELTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Elicio Therapeutics, Inc. - Common Stock stock?
Investing in Elicio Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ELTX chart and related analysis on metatrader.com as part of your research.